Therapeutic uses of penicillin g
Reading File
Finding Sources
Finding Sources
Searching PubMed
"penicillin G" AND therapeutic uses
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
I now have comprehensive data from multiple authoritative textbooks. Here is the complete answer:
Therapeutic Uses of Penicillin G (Benzylpenicillin)
Penicillin G is a natural penicillin with a narrow but clinically important spectrum. It is active primarily against gram-positive bacteria, most anaerobes, and several spirochetes. It is acid-labile (destroyed by stomach acid), so it is given parenterally (IV or IM) for systemic infections; oral use is not practical. It is 60% protein-bound and has a very short half-life (~30 minutes), so it must be given frequently or as a repository (depot) preparation.
1. Streptococcal Infections
a) Group A Streptococcus (S. pyogenes)
Penicillin G remains the drug of choice - no penicillin-resistant Group A streptococcal isolates have ever been documented.
- Pharyngitis: preferred oral therapy is penicillin V (more acid-stable), 500 mg twice daily for 10 days - penicillin treatment reduces risk of subsequent acute rheumatic fever.
- Erysipelas and cellulitis: oral penicillin V is effective.
- Necrotizing fasciitis/toxic shock: penicillin G + clindamycin (clindamycin reduces streptococcal toxin production).
b) Viridans Group Streptococcal Endocarditis (native valve)
- Highly penicillin-susceptible organisms: 12-20 million units/day IV for 4 weeks (or 2 weeks with gentamicin added).
- Quantitative sensitivity testing guides dosing and combination therapy decisions.
c) Group B Streptococcus (S. agalactiae)
- Neonatal meningitis and severe GBS infection: penicillin G is the drug of choice.
- Neonatal GBS meningitis: up to 450,000-500,000 units/kg/day divided Q4-6h.
2. Pneumococcal (S. pneumoniae) Infections
- Drug of choice for penicillin-sensitive strains - regimens of 12-24 million units/day IV for 7-14 days.
- For pneumococcal meningitis: due to risk of β-lactam resistance, empiric therapy should use vancomycin + a 3rd-generation cephalosporin until sensitivity is confirmed; dexamethasone given before or with antibiotics improves outcomes.
- Resistance is increasing (especially in children), so susceptibility testing is essential.
(Goodman & Gilman's The Pharmacological Basis of Therapeutics, p. 1170-1171)
3. Syphilis (Treponema pallidum)
Penicillin G is the only proven therapy for all stages of syphilis. There are no proven alternatives in pregnancy - penicillin-allergic pregnant women must undergo acute desensitization.
| Stage | Preparation | Dose |
|---|---|---|
| Primary, secondary, early latent (<1 yr) | Benzathine penicillin G IM | 2.4 million units × 1 (or 1-3 weekly doses) |
| Late latent or unknown duration | Benzathine penicillin G IM | 2.4 million units Q7 days × 3 doses |
| Neurosyphilis / cardiovascular syphilis | Aqueous penicillin G IV | 18-24 million units/day × 10-14 days |
| Congenital syphilis (neonate) | Aqueous penicillin G IV | 100,000-150,000 units/kg/day × 10 days |
- Jarisch-Herxheimer reaction may occur in secondary syphilis (fever, chills, myalgias within hours of first dose due to spirochetal antigen release) - manage with antipyretics; do not stop therapy.
(Harriet Lane Handbook, 23rd ed.; Goodman & Gilman's, p. 1171)
4. Meningococcal Infections (Neisseria meningitidis)
- Penicillin G is an alternative to 3rd-generation cephalosporins for confirmed sensitive meningococcal infections (N. meningitidis remains highly sensitive in most cases).
- High-dose IV penicillin G is required.
- Does not eliminate the meningococcal carrier state, so it is not used for chemoprophylaxis after exposure.
5. Anaerobic Infections
- Pulmonary and periodontal infections (mild-moderate): penicillin G or V 250 mg QID orally.
- Severe infections: 12-24 million units IV daily.
- Clostridial gas gangrene: penicillin G 12-24 million units/day IV plus clindamycin, combined with surgical debridement.
- Tetanus (C. tetani): antibiotics have minimal effect on outcome; debridement and tetanus immune globulin are the mainstays.
- Note: Bacteroides fragilis is resistant to penicillins (produces a β-lactamase/cephalosporinase).
6. Actinomycosis (Actinomyces israelii)
- Penicillin G is the drug of choice for all forms.
- Dose: 18-24 million units IV/day for 6 weeks, often followed by oral therapy.
- Surgical drainage or excision may be required.
7. Listeria monocytogenes Infections
- Ampicillin or penicillin G are drugs of choice (gentamicin added for immunosuppressed patients with meningitis).
- Recommended dose: 18-24 million units/day parenterally for at least 2 weeks; endocarditis requires at least 4 weeks.
8. Leptospirosis
- Penicillin G is susceptible and used for leptospirosis (Leptospira spp.).
9. Pasteurella multocida (Animal Bite Wounds)
- Susceptible to penicillin G and ampicillin.
- Note: resistant to penicillinase-resistant penicillins (oxacillin, dicloxacillin) and first-generation cephalosporins.
10. Rat-Bite Fever (Streptobacillus moniliformis)
- Penicillin G is effective against S. moniliformis.
Prophylactic Uses
| Indication | Regimen |
|---|---|
| Rheumatic fever prevention | Oral penicillin V/G 200,000 units Q12h, OR benzathine penicillin G 1.2 million units IM once monthly |
| Asplenia (functional/anatomic) | Penicillin V prophylaxis (plus vaccination against encapsulated organisms) |
(Goodman & Gilman's The Pharmacological Basis of Therapeutics, p. 1171)
Preparations Summary
| Form | Route | Duration | Key Use |
|---|---|---|---|
| Aqueous penicillin G (K+ or Na+ salt) | IV / IM | t½ ~30 min | Acute/severe infections - meningitis, gas gangrene, neurosyphilis, endocarditis |
| Penicillin G procaine | IM only | ~24h (once daily) | Moderate infections |
| Penicillin G benzathine (Bicillin L-A) | IM only | ~26 days | Syphilis, RF prophylaxis, GAS pharyngitis |
| Bicillin C-R (benzathine + procaine) | IM only | Intermediate | GAS infections in children |
Important: Repository forms (benzathine, procaine) must never be given IV - cardiac arrest and death can result.
What Penicillin G Does NOT Cover
- Most S. aureus (>90% resistant via β-lactamase)
- MRSA / MRSE (all β-lactams ineffective)
- Most gram-negative rods (poor gram-negative penetration)
- Bacteroides fragilis
- Atypicals (Mycoplasma, Chlamydia, Legionella)
- Fungi, viruses, parasites
(Sources: Goodman & Gilman's The Pharmacological Basis of Therapeutics, 14e, pp. 1170-1171; The Harriet Lane Handbook 23e; Jawetz Medical Microbiology 28e)
Recent evidence note: A 2024 systematic review/meta-analysis (PMID 38661311) on neurosyphilis confirms penicillin G remains the standard but reviews alternatives for penicillin-allergic patients - no major change to established regimens. A 2025 meta-analysis (PMID 41671009) confirms benzathine penicillin G treatment of gestational syphilis in the third trimester significantly reduces congenital syphilis incidence.
This is a shared conversation. Sign in to Orris to start your own chat.